State Street Takes 5.1 Percent Stake in Applied Biosystems | GenomeWeb
NEW YORK (GenomeWeb News) – Boston-based State Street Bank and Trust disclosed in a filing with the US Securities and Exchange Commission that it now holds a 5.1 percent stake in Applied Biosystems.
 
According to Monday’s filing, State Street owns 8,590,589 shares of ABI’s stock. The bank said in the filing that the shares “were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.